SEARCH

SEARCH BY CITATION

References

  • 1
    Maggi CA, Giachetti A, Dey RD, Said SI. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev 1995;75:277 322.
  • 2
    Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 1996;48:113 178.
  • 3
    Maggi CA. The effects of tachykinins on inflammatory and immune cells. Regul Pept 1997;70:75 90.
  • 4
    Erspamer V. The tachykinin peptide family. Trends Neurosci 1981;4:267 270.
  • 5
    Cascieri MA, Huang RR, Fong TM, Cheung AH, Sadowski S, Ber E, Strader CD. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 1992;41:1096 1099.
  • 6
    Nakanishi S. Mammalian tachykinin receptors. Ann Rev Neurosci 1991;14:123 136.
  • 7
    Rameshwar P. Substance P: a regulatory neuropeptide for hematopoiesis and immune functions. Clin Immunol Immunopathol 1997;85:129 133.
  • 8
    Harmar AJ, Hyde V, Chapman K. Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat substance P precursor. FEBS Lett 1990;275:22 24.
  • 9
    Otsuka M & Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993;73:229 308.
  • 10
    Lundberg JM, Franco-cereceda A, Lou Y, Modin A, Pernow J. Differential release of classical transmitters and peptides. In: Stjauml;rneL, GreengardP, GrillnerS, HükfeltT, OttosonD. Molecular and cellular mechanisms of neurotransmitter release. New York: Raven, 1994:223 234.
  • 11
    Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progr Neurobiol 1995;45:1 98.
  • 12
    Lundberg JM, Hüfelt T, Martling C-R, Saria A, Cuello C. SubstanceP-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984;235:251 261.
  • 13
    Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med 1995;151:548 553.
  • 14
    Martling C-R, Theodorsson-norheim E, Lundberg JM. Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci 1987;40:1633 1643.
  • 15
    Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646 652.
  •  15a. 
    Heaney LG, Cross LJM, McGarvey LPA, Buchanan KD, Ennis M, Shaw M. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. Thorax 1998;53:357 362.
  • 16
    Hazbun ME, Hamilton R, Holian A, Eschenbacher WL. Ozone-induced increases in substance P and 8-epi-prostaglandin F2a in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568 572.
  • 17
    Krishna MT, Springall DR, Meng Q-H, et al. Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med 1997;156:943 950.
  • 18
    Tomaki M, Ichinose M, Miura M, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995;151:613 617.
  • 19
    Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J 1994;7:2169 2173.
  • 20
    Lundberg JM, Brodin E, Saria A. Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs. Acta Physiol Scand 1983;119:243 252.
  • 21
    Nilsson G, Alving K, Ahlstedt S, Hükfelt T, Lundberg JM. Peptidergic innervation of rat lymphoid tissue and lung: relation to mast cells and sensitivity to capsaicin and immunization. Cell Tissue Res 1990;262:125 133.
  • 22
    Luts A, Uddman R, Alm P, Basterra J, Sundler F. Peptide-containing nerve fibers in human airways: distribution and coexistence pattern. Int Arch Allergy Immunol 1993;101:52 60.
  • 23
    Bowden JJ & Gibbins IL. Relative density of substanceP-immunoreactive (SP-IR) nerve fibers in the tracheal epithelium of a range of species. FASEB J 1992;6:A1276.
  • 24
    Sheldrick RLG, Rabe KF, Fischer A, Magnussen H, Coleman RA. Further evidence that tachykinin-induced contraction of human isolated bronchus is mediated only by NK2 receptors. Neuropeptides 1995;29:281 292.
  • 25
    Hislop AA, Wharton J, Allen KM, Polak JM, Haworth SG. Immunohistochemical localization of peptide-containing nerves in human airways: age-related changes. Am J Respir Cell Mol Biol 1990;3:191 198.
  • 26
    Springall DR, Polak JM, Howard L, et al. Persistence of intrinsic neurones and possible phenotypic changes after extrinsic denervation of human respiratory tract by heart-lung transplantation. Am Rev Respir Dis 1990;141:1538 1546.
  • 27
    Fischer A, McGregor GP, Saria A, Phillippin B, Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996;98:2284 2291.
  • 28
    Hoyle GW, Graham RG, Finkelstein JB, Thi Nguyen K-P, Gozal D, Friedman M. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998;18:149 157.
  • 29
    Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1991;4:673 682.
  • 30
    Howarth PH, Springall DR, Redington AE, Djukanovic R, Holgate S, Polak J. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol 1995;3:288 296.
  • 31
    Chanez P, Springall DR, Vignola A, et al. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med 1998;158:985 990.
  • 32
    Weinstock JL, Blum A, Walder J, Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 1988;141:961 966.
  • 33
    Weinstock JV & Blum AM. Tachykinin production in granulomas of murine schistosomiasis mansoni. J Immunol 1989;142:3256 3261.
  • 34
    Metwali A, Blum AM, Ferraris L, Klein JS, Fiocchi C, Weinstock JV. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol 1994;52:69 78.
  • 35
    Killingsworth CR, Shore SA, Alessandrini F, Dey RD, Paulauskis JD. Rat alveolar macrophages express preprotachykinin gene-I mRNA- encoding tachykinins. Am J Physiol 1997;273:L1073 L1081.
  • 36
    Kaltreider HB, Ichikawa S, Byrd PK, et al. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 1997;16:133 144.
  • 37
    Ho W-Z, Lai J-P, Zhu X-H, Uvaydova M, Douglas SD. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997;159:5654 5660.
  • 38
    Germonpré PR, Bullock GR, Lambrecht BN, et al. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 1999;14:776 782.
  • 39
    Lai J-P, Douglas ST, Rappaport E, Wu JM, Ho W-Z. Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol 1998;91:121 128.
  • 40
    Lai J-P, Douglas SD, Ho W-Z. Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998;86:80 86.
  • 41
    De Giorio R, Tazzari PL, Barbara G, Stanghellini V, Corinaldesi R. Detection of substance P immunoreactivity in human peripheral leukocytes. J Neuroimmunol 1998;82:175 181.
  • 42
    Lambrecht BN, Germonpré PR, Everaert EG, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999;29:3815 3825.
  • 43
    Maggi CA, Patacchini R, Rovero P, Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol 1993;13:23 93.
  • 44
    Regoli D, Boudon A, Fauchäre J-L. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994;46:551 599.
  • 45
    Gerard NP, Bao L, He XP, Gerard C. Molecular aspects of the tachykinin receptors. Regul Pept 1993;43:21 35.
  • 46
    Hopkins B, Powell S, Danks P, Briggs I, Graham A. Isolation and characterisation of the human lung NK-1 receptor cDNA. Biochem Biophys Res Commun 1991;180:1110 1117.
  • 47
    Gerard NP, Garraway LA, Eddy RL, et al. Human substance P receptor (NK1): organization of the gene, chromosome localisation, and functional expression of cDNA clones. Biochemistry 1991;30:10640 10646.
  • 48
    Graham A, Hopkins B, Powell S, Danks P, Briggs I. Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends. Biochem Biophys Res Commun 1991;177:8 16.
  • 49
    Nakajima Y, Tsuchida K, Negishi M, Ito S, Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem 1992;267:2437 2441.
  • 50
    Snider RM, Constantine JW, Lowe Ja III, et al. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 1991;251:435 437.
  • 51
    Garret C, Carruette A, Fardin V, et al. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Nat Acad Sci USA 1991;88:10208 10211.
  • 52
    Oury-donat F, Lefevre IA, Thurneyssen O, et al. SR 140333, a novel, selective, and potent nonpeptide antagonist of the NK1 tachykinin receptor: characterization on the U373MG cell line. J Neurochem 1994;62:1399 1407.
  • 53
    Advenier C, Lagente V, Boichot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough. Eur Respir J 1997;10:1892 1906.
  • 54
    Hoover DB & Hancock JC. Autoradiographic localization of substance P binding sites in guinea pig airways. J Auton Nerv Syst 1987;19:171 174.
  • 55
    Burcher E, Watkins DJ, O'flynn N. Autoradiographic localization of both substance P and neurokinin A binding sites in guinea pig lung. Pulmon Pharmacol 1989;1:201 203.
  • 56
    Black J, Diment L, Armour C, Alouan L, Johnson P. Distribution of substance P receptors in rabbit airways, functional and autoradiographic studies. J Pharmacol Exp Ther 1990;253:381 386.
  • 57
    Zeng XP, Lavielle S, Burcher E. Evidence for tachykinin NK-2 receptors in guinea-pig airways from binding and functional studies, using [I-125]-[Lys( ),Tyr(I-2)( ),MeLeu( ),NIe( )]-NKA( ) 579104–10. Neuropeptides 1994;26:1 9.
  • 58
    Haley KJ, Sunday ME, Osathanadonth R, et al. Immunolocalization of the NK-2 receptor in developing lung. Am J Respir Crit Care Med 1998;157:A546.
  • 59
    Bai TR, Zhou D, Weir T, et al. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway disease. Am J Physiol 1995;269:L309 L317.
  • 60
    Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 1993;11:1 7.
  • 61
    Katsunuma T, Mak JCW, Barnes PJ. Glucocorticoids reduce tachykinin NK2 receptor expression in bovine tracheal smooth muscle. Eur J Pharmacol 1998;344:99 106.
  • 62
    Hakonarson H, Guerra FM, Shanbaky I, Grunstein MM. Altered neurokinin receptor expression and function in atopic asthmatic sensitized airway sensitized smooth muscle. Am J Respir Crit Care Med 1998;157:A490.
  • 63
    Ireland SJ, Bailey F, Cook A, Hagan RM, Jordan CC, Stephens-smith ML. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol 1991;103:1463 1469.
  • 64
    Martin CAE, Naline E, Emonds-alt X, Advenier C. Influence of (+/−)-CP-96,345 and SR 48968 on electrical field stimulation of the isolated guinea-pig main bronchus. Eur J Pharmacol 1992;224:137 143.
  • 65
    Bertrand C, Nadel JA, Graf PD, Geppetti P. Capsaicin increases airflow resistance in guinea pigs in vivo by activating both NK2 and NK1 tachykinin receptors. Am Rev Respir Dis 1993;148:909 914.
  • 66
    Foulon DM, Champion E, Masson P, Rodger IW, Jones TR. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs. Am Rev Respir Dis 1993;148:915 921.
  • 67
    Boni P, Ballati L, Evangelista S. Tachykinin NK1 and NK2 receptors mediate the non-cholinergic bronchospastic response to capsaicin and vagal stimulation in guinea-pigs. J Auton Pharmacol 1995;15:49 54.
  • 68
    Joos GF, Kips JC, Pauwels RA. In vivo characterization of the tachykinin receptors involved in the direct and indirect bronchoconstrictor effect of tachykinins in the rat. Am J Respir Crit Care Med 1994;149:1160 1166.
  • 69
    Joos GF, Lefebvre RA, Bullock GR, Pauwels RA. Role of 5-hydro-xytryptamine and mast cells in the tachykinin-induced contraction of rat trachea in vitro. Eur J Pharmacol 1997;338:259 268.
  • 70
    Naline E, Devillier P, Drapeau G, et al. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis 1989;140:679 686.
  • 71
    Advenier C, Naline E, Toty L, et al. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors. Am Rev Respir Dis 1992;146:1177 1181.
  • 72
    Naline E, Molimard M, Regoli D, Emonds-alt X, Bellamy JF, Advenier C. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. Am J Physiol 1996;271:L763 767.
  • 73
    Finney MJB, Karlsson JA, Persson CGA. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. Br J Pharmacol 1985;85:29 36.
  • 74
    Advenier C, Naline E, Drapeau G, Regoli D. Relative potencies of neurokinins in guinea-pig trachea and human bronchus. Eur J Pharmacol 1987;139:133 137.
  • 75
    Frossard N & Barnes PJ. Effect of tachykinins in small human airways. Neuropeptides 1991;19:157 161.
  • 76
    Ben-jebria A, Marthan R, Rossetti M, Savineau J-P. Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br J Pharmacol 1993;109:131 136.
  • 77
    Björck T, Gustafsson L, Dahlen S-E. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 1992;145:1087 1091.
  • 78
    Joos GF, Germonpré PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J 1994;7:1161 1171.
  • 79
    Joos GF, Van Schoor J, Kips JC, Pauwels RA. The effect of inhaled FK 244, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokininA-induced bronchoconstriction in asthmatics. Am J Respir Crit Care Med 1996;153:1781 1784.
  • 80
    Crimi N, Palermo F, Oliveri R, et al. Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects. Clin Allergy 1988;18:375 382.
  • 81
    Joos GF, Pauwels RA, Van Der Straeten ME. The effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in subjects with asthma. J Allergy Clin Immunol 1989;83:663 668.
  • 82
    Crimi N, Palermo F, Oliveri R, et al. Influence of antihistamine (astemizole) and anticholinergic drugs (ipratropium bromide) on bronchoconstriction induced by substance P. Ann Allergy 1990;65:115 120.
  • 83
    Crimi N, Oliveri R, Polosa R, Palermo F, Mistretta A. The effect of oral terfenadine on neurokinin-A induced bronchoconstriction. J Allergy Clin Immunol 1993;91:1096 1098.
  • 84
    Tanaka DT & Grunstein MM. Mechanisms of substance P-induced contraction of rabbit airway smooth muscle. J Appl Physiol 1984;57:1551 1557.
  • 85
    Joos GF, Pauwels RA, Van Der Straeten ME. The mechanism of tachykinin-induced bronchoconstriction in the rat. Am Rev Respir Dis 1988;137:1038 1044.
  • 86
    Szarek JL, Zhang JZ, Gruetter CA. 5-HT2 receptors augment cholinergic nerve-mediated contraction of rat bronchi. Eur J Pharmacol 1993;231:339 346.
  • 87
    Jancsó N, Jancsó-gábor A, Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and pretreatment with capsaicin. Br J Pharmacol Chemother 1967;31:138 151.
  • 88
    Jancsó N, Jancsó-gábor A, Szolcsányi J. The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br J Pharmacol Chemother 1968;33:32 41.
  • 89
    Allen TH & Dralpvats PD. Spectrophotometric measurement of traces of the dye T-1824 by extraction with cellophane from blood serum and urine of normal dogs. Am J Physiol 1948;154:27 38.
  • 90
    Rogers DF, Boschetto P, Barnes PJ. Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods 1989;21:309 315.
  • 91
    Lundberg JM & Saria A. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 1983;302:215 253.
  • 92
    Qian Y, Emonds-alt X, Advenier C. Effects of capsaicin, (+/−)-CP 96,345 and SR 48968 on the bradykinin-induced airways microvascular leakage in guinea-pigs. Pulmon Pharmacol 1993;6:63 67.
  • 93
    Delay-goyet P, Franco-cerceda A, Gonsalves SF, Clingan CA, Lowe Ja III, Lundberg JM. CP-96,345 antagonism of NK1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effects. Eur J Pharmacol 1992;222:213 218.
  • 94
    Bertrand C, Geppetti P, Baker J, Yamawaki I, Nadel JA. Tachykinins, via NK1 receptor activation, play a relevant role in plasma protein extravasation evoked by allergen challenge in the airways of sensitized guinea-pigs. Regul Pept 1993;46:214 216.
  • 95
    Abelli L, Maggi CA, Rovero P, et al. Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for involvement of NK1 receptors. J Auton Pharmacol 1991;11:267 275.
  • 96
    Eglezos A, Giuliani S, Viti G, Maggi CA. Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors. Eur J Pharmacol 1991;209:277 279.
  • 97
    Hirayama Y, Lei YH, Barnes PJ, Rogers DF. Effects of 2 novel tachykinin antagonists, FK 224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo. Br J Pharmacol 1993;108:844 851.
  • 98
    Tousignant C, Chan CC, Guevremont D, et al. NK2 receptors mediate plasma extravasation in guinea-pig lower airways. Br J Pharmacol 1993;108:383 386.
  • 99
    Bowden JJ, Garland AM, Baluk P, et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 1994;91:8964 8968.
  • 100
    Hirata A, Baluk P, Fujiwara T, McDonald DM. Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy. Am J Physiol 1995;13:L403 L418.
  • 101
    Woie K, Koller ME, Heyeraas KJ, Reed RK. Neurogenic inflammation in rat trachea is accompanied by increased negativity of interstitial fluid pressure. Circ Res 1993;73:839 845.
  • 102
    Delaunois A, Gustin P, Ansay M. Role of neuropeptides in acetylcholine-induced edema in isolated and perfused rabbit lungs. J Pharmacol Exp Ther 1993;266:483 491.
  • 103
    Delaunois A, Gustin P, Ansay M. Effects of capsaicin on the endothelial permeability in isolated and perfused rabbit lungs. Fundam Clin Pharmacol 1993;7:81 91.
  • 104
    Saria A, Hua X, Skofitsch G, Lundberg JM. Inhibition of compound 48/80-induced vascular protein leakage by pretreatment with capsaicin and a substance P antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 1984;328:9 15.
  • 105
    Huang Z, Byun B, Matsubara T, Moskowitz MA. Time-dependent blockade of neurogenic plasma extravasation by 5-HT1B/D agonists and endopeptidase 24.11. Br J Pharmacol 1993;108:331 335.
  • 106
    Hua XY & Yaksh TL. Pharmacology of the effects of bradykinin, serotonin, and histamine on the release of calcitonin gene related peptide fromC-fiber terminals in the rat trachea. J Neurosci 1993;13:1947 1953.
  • 107
    Hua XY & Yaksh TL. Release of calcitonin gene-related peptide and tachykinins from the rat trachea. Peptides 1992;13:113 120.
  • 108
    Buckner CK, Dea D, Liberati N, Krell RD. A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthesized guinea-pig. J Pharmacol Exp Ther 1991;257:26 34.
  • 109
    Ward JK, Fox AJ, Barnes PJ, Belvisi MG. Inhibition of excitatory non-adrenergic non-cholinergic bronchoconstriction in guinea-pig airways in vitro by activation of an atypical 5 HT receptor. Br J Pharmacol 1994;111:1095 1102.
  • 110
    Ichinose M, Belvisi MG, Barnes PJ. Histamine H3-receptors inhibit neurogenic microvascular leakage in airways . J Appl Physiol 1990;68:21 25.
  • 111
    Ohkubo T, Shibata M, Inoue M, Kaya H, Takahashi H. Regulation of substance P release mediated via prejunctional histamine H3 receptors. Eur J Pharmacol 1995;273:83 88.
  • 112
    Belvisi MG, Rogers DF, Barnes PJ. Neurogenic plasma extravasation: inhibition by morphine in guinea-pig airways in vivo. J Appl Physiol 1989;66:268 272.
  • 113
    Morikawa M, Aikawa T, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Inhibitory action of prostaglandin E1 on neurogenic plasma extravasation in rat airways. Eur J Pharmacol 1992;217:31 35.
  • 114
    Tokuyama K, Yokoyama T, Arakawa H, Morikawa A, Kuroume T. Effects of cilostazol, a cyclic nucleotide phosphodiesterase III inhibitor, on substance P-induced airflow obstruction and airway microvascular leakage in guinea pigs. Pharmacology 1994;48:301 307.
  • 115
    Martin CAE & Advenier C. Effects of cromakalim on bradykinin-, histamine-and substance P-induced airway microvascular leakage in the guinea-pig. Eur J Pharmacol 1993;239:119 126.
  • 116
    Fick RB, Metzger WJ, Richerson HB, et al. Increased bronchovascular permeability after allergen exposure in sensitive asthmatics. J Appl Physiol 1987;63:1147 1155.
  • 117
    Fick RB, Richerson HB, Zavala DC, Hunnighake GW. Bronchoalveolar lavage in allergic asthmatics. Am Rev Respir Dis 1987;135:1204 1209.
  • 118
    Rajakulasingam K, Polosa R, Lau LCK, Church MK, Holgate ST, Howarth PH. Nasal effects of bradykinin and capsaicin: influence on plasma protein leakage and role of sensory neurons. J Appl Physiol 1992;72:1418 1424.
  • 119
    Geppetti P, Fusco BM, Marabini S, Maggi CA, Fanciullacci M, Sicuteri F. Secretion, pain and sneezing induced by application of capsaicin to the nasal mucosa in man. Br J Pharmacol 1988;93:503 514.
  • 120
    Stjärne P, Lundblad L, Lundberg JM, Anggard A. Capsaicin and nicotine sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989;96:693 701.
  • 121
    Mosimann B, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance-P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993;92:95 104.
  • 122
    Nieber K, Baumgarten C, Rathsack R, et al. Effect of azelastine on substance-P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin Exp Allergy 1993;23:69 71.
  • 123
    Devillier P, Dessanges JF, Rakotosihanaka F, et al. Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. Eur Respir J 1988;1:356 361.
  • 124
    Guarnaccia S, Baraniuk JN, Bellanti J, Duina M. Calcitonin gene-related peptide nasal provocation in humans. Ann Allergy 1999;72:515 519.
  • 125
    Di Maria GU, Bellofiore S, Geppetti P. Regulation of airway neurogenic inflammation by neutral endopeptidase. Eur Respir J 1998;12:1454 1462.
  • 126
    Koehne P, Schäper C, Graf K, Kunkel G. Neutral endopeptidase 24.11: its physiologic and possibly pathophysiologic role in inflammation with special effect on respiratory inflammation. Allergy 1998;53:1023 1042.
  • 127
    Shore SA, Stimler-gerard NP, Coats SR, Drazen JM. SubstanceP-induced bronchoconstriction in the guinea-pig: enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis 1988;137:331 336.
  • 128
    Baraniuk JN, Ohkubo K, Kwon OJ, et al. Localization of neutral endopeptidase (NEP) mRNA in human bronchi. Eur Respir J 1995;8:1458 1464.
  • 129
    Haver K, Kobzik L, Shore SA. Neutral endopeptidase activity and localization in human lungs and airways. Am Rev Respir Dis 1993;147:A15.
  • 130
    Borson DB & Gruenert DC. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol 1991;260:L83 L89.
  • 131
    Sont JK, Van Krieken JHJM, Van Klink HCJ, et al. Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid-versus nonsteroid-treated patients with atopic asthma. Am J Respir Cell Mol Biol 1997;16:549 556.
  • 132
    Cheung D, Bel EH, Den Hartigh J, Dijkman JH, Sterk PJ. The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis 1992;145:1275 1280.
  • 133
    Cheung D, Timmers MC, Zwinderinan AH, Den Hartigh J, Dijkman JH, Sterk PJ. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo. Am Rev Respir Dis 1993;148:1467 1473.
  • 134
    Crimi N, Palermo F, Oliveri R, Raccuglia DR, Pulverenti G, Mistretta A. Inhibition of neutral endopeptidase potentiates bronchoconstriction induced by neurokinin A in asthmatic patients. Clin Exp Immunol 1994;24:115 1120.
  • 135
    Joos GF, Kips JC, Pauwels RA. A role for neutral endopeptidase in asthma? Clin Exp Allergy 1994;24:91 93.
  • 136
    Fewtrell CMS, Foreman JC, Jordan CC, Oehme P, Renner H, Stewart JM. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol 1982;330:393 411.
  • 137
    Cross LJM, Heaney LG, Ennis M. Further characterisation of substance P induced histamine release from human bronchoalveolar lavage mast cells. Inflamm Res 1996;45:S11 S12.
  • 138
    Heaney LG, Cross LJM, Stanford CF, Ennis M. Substance-P induces histamine-release from human pulmonary mast-cells. Clin Exp Allergy 1995;25:179 186.
  • 139
    Ansel JC, Brown JR, Payan DG, Brown MA. Substance-P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478 4485.
  • 140
    Janiszewski J, Bienenstock J, Blennerhassett MG. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 1994;267:C138 C145.
  • 141
    Mousli M, Bueb J-L, Bronner C, Rouot B, Landry Y. G-protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 1992;11:358 362.
  • 142
    Krumins SA & Broomfield CA. C-terminal substance-P fragments elicit histamine release from a murine mast cell line. Neuropeptides 1993;24:5 10.
  • 143
    Joos GF, Lefebvre RA, Bullock G, Pauwels RA. Role of 5-hydroxytryptamine and mast cells in the tachykinin-induced contraction of rat trachea in vitro. Eur J Pharmacol 1997;338:259 268.
  • 144
    Germonpré PR, Joos GF, Everaert E, Kips JC, Pauwels RA. Characterization of neurogenic inflammation in the airways of two highly inbred rat strains. Am J Respir Crit Care Med 1995;152:1796 1804.
  • 145
    Okada T, Hirayama Y, Kishi S, Miyayasu K, Hiroi J, Fujii T. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells. Inflamm Res 1999;48:274 279.
  • 146
    Germonpré PR, Joos GF, Pauwels RA. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro. Br J Pharmacol 1998;123:1571 1578.
  • 147
    Zimmerman BJ, Anderson DC, Granger DN. Neuropeptides promote neutrophil adherence to endothelial cell monolayers. Am J Physiol 1992;263:G678 G682.
  • 148
    Iwamoto I, Nakagawa N, Yamazaki H, Kimura A, Tomioka H, Yoshida S. Mechanism for substance-P-induced activation of human neutrophils and eosinophils. Regul Pept 1993;46:228 330.
  • 149
    Wiedermann CJ, Wieddermann FJ, Apperl A, Kieselbach G, Konwalinka G, Braunsteiner H. In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P. Naunyn-Schmiedeberg's Arch Pharmacol 1989;340:185 190.
  • 150
    Carolan EJ & Casale TB. Effects of neuropeptides on neutrophil migration through noncellular and endothelial barriers. J Allergy Clin Immunol 1993;92:589 598.
  • 151
    Hoshino H, Lötvall J, Skoogh B-E, Linden A. Neutrophil recruitment by interleukin-17 into rat airways in vivo. Am J Respir Crit Care Med 1999;159:1423 1428.
  • 152
    Wozniak A, Betts WH, McLennan G, Scicchitano R. Activation of human neutrophils by tachykinins: effect on FMLP- and PAF-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity. Immunology 1993;78:629 634.
  • 153
    Tanabe T, Otani H, Bao L, et al. Intracellular signaling pathway of substance P-induced superoxide production in human neutrophils. Eur J Pharmacol 1996;299:187 195.
  • 154
    Serra MC, Calzetti F, Ceska M, Cassatella MA. Effect of substance P on superoxide anion and IL-8 production by human PMNL. Immunology 1994;82:63 69.
  • 155
    Marasco WA, Showell HJ, Becker EL. Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil. Biochem Biophys Res Commun 1981;99:1065 1072.
  • 156
    Wiedermann FJ, Kahler CM, Reinisch N, Wiedermann CJ. Induction of normal human eosinophil migration in vitro by substance-P . Acta Haematol 1993;89:213 215.
  • 157
    El-shazly AE, Masuyama K, Eura M, Ishikawa T. Immunoregulatory effect of substance P in human eosinophil migratory function. Immunol Invest 1996;25:191 201.
  • 158
    Numao T & Agrawal DK. Neuropeptides modulate human eosinophil chemotaxis. J Immunol 1992;149:3309 3315.
  • 159
    Schratzberger P, Reinisch N, Prodinger WM, et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 1997;158:3895 3901.
  • 160
    Covas MJ, Pinto LA, Victorino RMM. Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection. Clin Exp Immunol 1994;96:384 388.
  • 161
    Calvo CF, Chavanel G, Senik A. Substance P enhances IL-2 expression in activated human T cells. J Immunol 1992;148:3498 3504.
  • 162
    Rameshwar P, Gascon P, Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance-P and related tachykinins. J Immunol 1993;151:2484 2496.
  • 163
    Nio DA, Moylan RN, Roche JK. Modulation of T lymphocyte function by neuropeptides – evidence for their role as local immunoregulatory elements. J Immunol 1993;150:5281 5288.
  • 164
    Carucci JA, Auci DL, Herrick CA, Durkin HG. Neuropeptide-mediated regulation of hapten-specific IgE responses in mice: substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro. J Leukoc Biol 1995;57:110 115.
  • 165
    Eglezos A, Andrews PV, Boyd RL, Helme RD. Tachykinin-mediated modulation of the primary antibody response in rats: evidence for mediation by an NK-2 receptor. J Neuroimmunol 1991;32:11 18.
  • 166
    Kavelaars A, Jeurissen F, Kunzel JVD, Vanroijen JH, Rijkers GT, Heijnen CJ. Substance P induces a rise in intracellular calcium concentration in human T-lymphocytes in vitro: evidence of a receptor-independent mechanism . J Immunol 1993;42:61 70.
  • 167
    Cook GA, Elliott D, Metwali A, et al. Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. J Immunol 1994;152:1830 1835.
  • 168
    Murris-espin M, Pinelli E, Pipy B, Leophonte P, Didier A. Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production. Allergy 1995;50:334 339.
  • 169
    Boichot E, Lagente V, Paubertbraquet M, Frossard N. Inhaled substance-P induces activation of alveolar macrophages and increases airway responses in the guinea-pig. Neuropeptides 1993;25:307 313.
  • 170
    Bar-shavit Z, Goldman R, Stabinsky Y, et al. Enhancement of phagocytosis: a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980;94:1445 1451.
  • 171
    Kimball ES, Persico FJ, Vaught JL. Substance P, neurokinin A, and neurokinin B induce generation ofIL-1 like activity in P388D1 cells. J Immunol 1988;141:3564 3569.
  • 172
    Kincy-cain T & Bost KL. Substance P-induced IL-12 production by murine macrophages. J Immunol 1997;158:2334 2339.
  • 173
    Brunelleschi S, Parenti A, Centi E, Giotti A, Fantozzi R. Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. Br J Pharmacol 1992;107:964 969.
  • 174
    Ho W-Z, Cnaan A, Li Y-H, et al. Substance P modulates human immunodeficiency virus replication in human peripheral blood-monocyte derived macrophages. AIDS Res Hum Retroviruses 1996;12:195 198.
  • 175
    Ruff MR, Wahl SM, Pert CB. Substance P mediated chemotaxis of human monocytes. Peptides 1985;6:107 111.
  • 176
    Lotz M, Vaughan JH, Carson DA. Effects of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218 1221.
  • 177
    Laurenzi MA, Persson MA, Dalsgaard CJ, Haegerstrand A. The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide. Scand J Immunol 1990;31:529 533.
  • 178
    Lieb K, Fiebich BL, Busse-grawitz M, Hull M, Berger M, Bauer J. Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1β and interleukin-6 in human monocytes: a re-examination. J Neuroimmunol 1996;67:77 81.
  • 179
    Derocq J-M, Sägui M, Blazy C, et al. Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonist. FEBS Lett 1996;399:321 325.
  • 180
    Kaltreider HB, Ichikawa S, Byrd PK, et al. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 1997;16:133 144.
  • 181
    Brunelleschi S, Guidotto S, Viano I, et al. Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study. Neuropeptides 1996;30:249 260.
  • 182
    Brunelleschi S, Vanni L, Ledda F, Giotti A, Maggi CA, Fantozzi R. Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol 1990;100:417 420.
  • 183
    Bost KL, Breeding SA, Pascual DW. Modulation of the mRNAs encoding the substance P and its receptor in rat macrophage by LPS. Reg Immunol 1992;4:105 112.
  • 184
    Lucey DR, Novak JM, Polonis VR, Liu Y, Gartner S. Characterization of substance P binding to human monocytes/macrophages. Clin Diagn Lab Immunol 1994;1:330 335.
  • 185
    Kavelaars A, Broeke D, Jeurissen F, et al. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production. J Immunol 1994;153:3691 3699.
  • 186
    Jeurissen F, Kavelaars A, Korstjens M, et al. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. J Immunol 1994;152:2987 2994.
  • 187
    Nilsson J, Von Euler AM, Dalsgaard C-J. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985;315:61 63.
  • 188
    Harrison NK, Dawes KE, Kwon OJ, Barnes PJ, Laurent GJ, Chung KF. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am J Physiol 1995;12:L278 L283.
  • 189
    Parenti A, Amerini S, Ledda F, Maggi CA, Ziche M. The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn Schmiedeberg's Arch Pharmacol 1996;353:475 481.
  • 190
    Kèhler CM, Sitte BA, Reinisch N, Wiedermann CJ. Stimulation of the chemotactic migration on human fibroblasts by substance P. Eur J Pharmacol 1993;249:281 286.
  • 191
    Ziche M, Morbidelli L, Pacini M, Dolara P, Maggi CA. NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol 1990;100:11 14.
  • 192
    Ziche M, Parenti A, Amerini S, Zawieja D, Maggi CA, Ledda F. Effect of the non-peptide blocker (+/−) CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblasts. Neuropeptides 1996;30:345 354.
  • 193
    Noveral JP & Grunstein MM. Tachykinin regulation of airway smooth muscle cell proliferation. Am J Physiol 1995;269:L339 L343.
  • 194
    Ziche M, Morbidelli L, Geppetti P, Maggi CA, Dolara P. Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity. Life Sci 1991;48:L7 11.
  • 195
    Wiedermann CJ, Auer B, Sitte B, Reinisch N, Schratzberger P, Kahler CM. Induction of endothelial cell differentiation into capillary-like structures by substance P. Eur J Pharmacol 1996;298:335 338.
  • 196
    Nakagawa N, Iwamoto I, Yoshida S. Effect of substance-P on the expression of an adhesion molecule ICAM-1 in human vascular endothelial cells. Regul Pept 1993;46:223 224.
  • 197
    Bertrand C, Geppetti P, Graf PD, Foresi A, Nadel JA. Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea pigs. Am J Physiol 1993;265:L507 L511.
  • 198
    Tiberio IFLC, Turco GMG, Leick-maldonado EA, et al. Effects of neurokinin depletion on airway inflammation induced by chronic antigen exposure. Am J Respir Crit Care Med 1997;155:1739 1747.
  • 199
    Ellis JL & Undem BJ. Antigen-induced enhancement of noncholinergic contractile responses to vagus nerve and electrical field stimulation in guinea pig isolated trachea. J Pharmacol Exp Ther 1992;262:646 653.
  • 200
    Ballati L, Evangelista S, Manzini S. Repeated antigen challenge induced airway hyperresponsiveness to neurokinin A and vagal non-adrenergic, non-cholinergic (NANC) stimulation in guinea-pigs. Life Sci 1992;51:PL119 124.
  • 201
    Nieri P, Daffonchio L, Omini C, Martinotti E, Breschi MC. Changes in airway reactivity to exogenous and endogenous acetylcholine and substance P after anaphylactic bronchoconstriction in anaesthetized guinea-pigs. J Auton Pharmacol 1992;12:403 409.
  • 202
    Ladenius ARC & Nijkamp FP. Capsaicin pretreatment of guinea pigs in vivo prevents ovalbumin-induced tracheal hyperreactivity in vitro. Eur J Pharmacol 1993;235:127 131.
  • 203
    Herd CM, Gozzard N, Page CP. Capsaicin pre-treatment prevents the development of antigen-induced airway hyperresponsiveness in neonatally immunised rabbits. Eur J Pharmacol 1995;282:111 119.
  • 204
    Kraneveld AD, Nijkamp FP, Van Oosterhout AJM. Role of neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs. Am J Respir Crit Care Med 1997;156:367 374.
  • 205
    Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP. Neurogenic amplification of immune complex inflammation. Science 1996;273:1722 1725.
  • 206
    Schuiling M, Zuidhof A, Zaagsma J, Meurs H. Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea-pigs. Am J Respir Crit Care Med 1999;159:423 430.
  • 207
    Schuiling M, Zuidhof A, Meurs H, Zaagsma J. Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammation cell influx in conscious, unrestrained guinea-pigs. Br J Pharmacol 1999;127:1030 1038.
  • 208
    Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992;340:1248 1251.
  • 209
    Lunde H, Hedner J, Svedmyr N. Lack of efficacy of 4 weeks treatment with the neurokinin receptor antagonist FK 224 in mild to moderate asthma. Eur Respir J 1994;7 Suppl 18:151s.
  • 210
    Fahy JV, Wong HH, Geppetti P, et al. Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Respir Crit Care Med 1995;152:879 884.
  • 211
    Ichinose M, Miura M, Yamauchi H, et al. A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am J Respir Crit Care Med 1996;153:936 941.
  • 212
    Van Schoor J, Joos G, Chasson B, Brouard R, Pauwels R. The effect of the oral nonpeptide NK2 receptor antagonist SR48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. Eur Respir J 1998;12:17 23.